The PE Ratio as of December 2024 (TTM) for MEI Pharma, Inc. (MEIP) is -0.35

According to MEI Pharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.35. This represents a change of -42.42% compared to the average of -0.61 of the last 4 quarters.

MEI Pharma, Inc. (MEIP) Historical PE Ratio (quarterly & annually)

How has MEIP PE Ratio performed in the past?

The mean historical PE Ratio of MEI Pharma, Inc. over the last ten years is -0.28. The current -0.35 PE Ratio has changed 12.36% with respect to the historical average. Over the past ten years (40 quarters), MEIP's PE Ratio was at its highest in in the September 2020 quarter at 123.48. The PE Ratio was at its lowest in in the March 2017 quarter at -20.25.

MEI Pharma, Inc. (MEIP) PE Ratio by Quarter and Year

Discovering the peaks and valleys of MEI Pharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MEI Pharma, Inc. (MEIP) Average PE Ratio

How has MEIP PE Ratio performed in the past?

The current PE Ratio of MEI Pharma, Inc. (MEIP) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

MEI Pharma, Inc. (MEIP) PE Ratio vs. Peers

How is MEIP’s PE Ratio compared to its peers?

MEI Pharma, Inc.’s PE Ratio is less than Magenta Therapeutics, Inc. (-0.15), greater than Kezar Life Sciences, Inc. (-5.01), less than Vincerx Pharma, Inc. (-0.32), less than Avenue Therapeutics, Inc. (-0.20), greater than Assembly Biosciences, Inc. (-2.39), greater than Neoleukin Therapeutics, Inc. (-5.86), greater than Instil Bio, Inc. (-1.89), less than CytomX Therapeutics, Inc. (6.75), greater than Achilles Therapeutics plc (-0.68), greater than Ocular Therapeutix, Inc. (-8.16), less than Spero Therapeutics, Inc. (17.42), greater than Acumen Pharmaceuticals, Inc. (-1.31), greater than HOOKIPA Pharma Inc. (-0.56), greater than Day One Biopharmaceuticals, Inc. (-14.64), greater than Inozyme Pharma, Inc. (-1.95), greater than Terns Pharmaceuticals, Inc. (-5.07), less than Revelation Biosciences, Inc. (-0.06), greater than Zura Bio Limited (-5.31), less than Phio Pharmaceuticals Corp. (-0.27), less than ZyVersa Therapeutics, Inc. (-0.00), greater than TransCode Therapeutics, Inc. (-3.52),

Build a custom stock screener for MEI Pharma, Inc. (MEIP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MEI Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MEI Pharma, Inc. (MEIP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MEI Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.